Cognition Therapeutics | 10-Q: Quarterly report
Cognition Therapeutics | 8-K: Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doyle John Brendan
Cognition Therapeutics | ARS: Annual Report to Security Holders
Cognition Therapeutics | DEFA14A: Others
Cognition Therapeutics | DEF 14A: Definitive information statements
Cognition Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cognition Therapeutics | 10-K: Annual report
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ricciardi Lisa
Cognition Therapeutics | 424B5: Prospectus
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 424B5: Prospectus
Cognition Therapeutics | 8-K: Current report
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Caggiano Anthony
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doyle John Brendan
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ricciardi Lisa
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Caggiano Anthony
Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ricciardi Lisa
No Data